Solute Clearance Evaluation and Filter Clotting Prediction in Continuous Renal Replacement Therapy

Area of Science:

• Nephrology
• Intensive Care Medicine
• Biomedical Engineering

Background:

• Unexpected filter clotting is a significant complication in continuous renal replacement therapy (CRRT).
• Reduced solute clearance often precedes filter clotting in CRRT.
• Predicting filter clotting is crucial for optimizing patient treatment and resource management.

Purpose of the Study:

• To investigate whether reduced solute clearance of low- and medium-molecular-weight molecules predicts filter clotting in CRRT.
• To identify specific solute clearance thresholds that indicate an increased risk of filter clotting.

Main Methods:

• A retrospective, observational study analyzing 775 continuous hemodiafiltration (CHDF) treatments in 230 ICU patients.
• Measurement of urea and myoglobin (Mb) solute clearances (CL/F) at 24 hours post-CHDF initiation.
• Multivariate logistic regression analysis to identify predictors of filter clotting within the subsequent 24 hours.

Main Results:

• Filter clotting occurred in 127 of the analyzed treatments.
• Significantly lower urea and Mb CL/F were observed at 24 hours in treatments that subsequently clotted.
• Urea CL/F < 94% and Mb CL/F < 64% at 24 hours were identified as significant predictors of filter clotting.

Conclusions:

• Lower urea and myoglobin solute clearance measured 24 hours after CRRT initiation are associated with an increased risk of filter clotting in the next 24 hours.
• These findings suggest that monitoring solute clearance may aid in predicting and potentially preventing unexpected filter clotting.
• Further research is warranted to confirm the clinical utility of urea and Mb CL/F measurements for avoiding filter clotting.